Subscribe to RSS
DOI: 10.1055/s-2004-835856
Prolyl Endopeptidase Inhibitors from the Leaves of Ginkgo biloba
Publication History
Received: March 24, 2004
Accepted: August 19, 2004
Publication Date:
10 January 2005 (online)
![](https://www.thieme-connect.de/media/plantamedica/200412/lookinside/thumbnails/10.1055-s-2004-835856-1.jpg)
Abstract
Prolyl endopeptidase (PEP, EC 3.4.21.26) hydrolyzes proline-containing neuropeptides, such as vasopressin, substance P, and thyrotropin-releasing hormone (TRH), and is suggested to participate in learning and memory processes. Ginkgo biloba leaves, upon examination for anti-amnestic constituents as new types of PEP inhibitors, showed significant PEP inhibition. PEP activity-guided fractionation and column chromatography of the MeOH extracts of G. biloba leaves resulted in the isolation of 6-(8′Z-pentadecenyl)salicylic acid (1) and 6-(10′Z-heptadecenyl)salicylic acid (2). The kinetic study indicated that compounds 1 and 2 are non-competitive inhibitors of prolyl endopeptidase with Ki values of 0.87 and 0.80 μM, respectively.
References
- 1 Cunningham D F, O’Connor B. Proline specific peptidase. Biochem Biophys Acta. 1997; 1343 160-86
- 2 Walter R, Shlank H, Glass J D, Schwartz I L, Kerenyi T D. Leucylglycinamide released from oxytocin by human uterine enzyme. Science. 1971; 173 827-9
- 3 Kalwant S, Porter A G. Purification and characterization of human brain prolyl endopeptidase. Biochem J. 1991; 276 237-44
- 4 Okada C, Mizuochi T, Shirasawa T, Morain P, Checler F. Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation-induced cell death. FEBS Lett. 2002; 512 163-7
- 5 Maes M, Goossens F, Scharpe S, Calabrese J, Desnyder R, Meltzer H Y. Alterations in plasma prolyl endopeptidase activity in depression, mania and schizophrenia: effects of antidepressants, mood stabilizers and antipsychotic drugs. Psych Res. 1995; 58 217-25
- 6 Aoyagi T, Wada T, Nagai M, Kojima F, Harada S, Takeuchi T, Takahashi H, Hirokawa K, Tsumita T. Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer’s disease. Experientia. 1990; 46 94-7
- 7 Maidment I. The use of Ginkgo biloba in the treatment of dementia. Psychiatric Bull. 2001; 25 353-6
- 8 Lichtblau D, Berger J M, Nakanishi K. Efficient extraction of ginkgolides and bilobalide form Ginkgo biloba leaves. J Nat Prod. 2002; 65 1501-4
- 9 Lee J S, Cho Y S, Park E J, Kim J W, Oh W K, Lee H S, Ahn J S. Phospholipase Cγ1 inhibitory principles from the sarcotestas of Ginkgo biloba . J Nat Prod. 1998; 61 867-71
- 10 Jaggy H, Koch E. Chemistry and biology of alkylphenols from Ginkgo biloba L. Pharmazie. 1997; 52 735-8
- 11 Itokawa H, Totsuka N, Nakahara K, Takeya K, Lepoittevin J -P, Asakawa Y. Antitumor principles from Ginkgo biloba L. Chem Pharm Bull. 1987; 35 3016-20
- 12 Fan W, Tezuka Y, Komatsu K, Namba T, Kadota S. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sacra S. H. Fu. Biol Pharm Bull. 1999; 22 157-61
- 13 Kimura K, Kawaguchi N, Yoshihama M, Kawanishi G. Staurosporine, a prolyl endopeptidase inhibitor. Agric Biol Chem. 1990; 54 3021-2
- 14 Sultanova N, Makhmoor T, Yasin A, Abilov Z A, Omurkamzinova V B, Atta-ur-Rahman , Choudhary M I. Isotamarixen - a new antioxidant and prolyl endopeptidase-inhibiting triterpenoid from Tamarix hispida . Planta Medica. 2004; 70 65-7
- 15 Kimura K, Kanou F, Takahashi H, Esumi Y, Uramoto M, Yoshihama M. Propeptin, a new inhibitor of prolyl endopeptidase produced by microbispora. I. fermentation, isolation and biological properties. J Antibiot. 1997; 50 373-8
- 16 Song K S, Raskin I. A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex . J Nat Prod. 2002; 65 76-8
- 17 Yoshimoto T, Walter R, Tsuru D. Proline-specific endopeptidase from Flavobacterium . J Biol Chem. 1980; 255 4786-92
Young-Sook Paik
College of Environment and Applied Chemistry
Kyung Hee University
Suwon, 449-701
South Korea
Fax: +82-31-202-7337
Email: paikys@khu.ac.kr